Recombinant mouse IgG2a kappa isotype control and mutants, mIgG2a D265A, N297A, and LALAPG, good for in vitro and in vivo studies. Low or no specific binding to mouse samples tested. More choices of recombinant mouse...
The best anti-DYKDDDDK-tag antibody and anti-c-Myc-tag antibody; for various in vitro and in vivo studies including protein purification. FLAG is a registered trade mark of Sigma Aldrich, and used here for informational purposes only.
Recombinant mouse IgG1 kappa isotype control and mIgG1 D265A isotype control mutant for in vitro and in vivo studies. Low or no specific binding to mouse samples tested. More choices of recombinant mouse IgG1 isotype...
Recombinant anti-mouse PD 1/ CD279 antibody(RMP1-14.1), which share the same variable region sequences with the rat anti-mouse PD-1 antibody (clone: RMP1-14), are produced from mammalian cells. Anti-mouse PD-1 / CD279 antibody (RMP1-14.1, rat IgG2a kappa)...
Recombinant anti-mouse CD8a monoclonal antibodies from the variable region sequences of the rat anti-mouse CD8a monoclonal antibody (clone number: YTS 169.4) are produced from mammalian cells and good for in vitro and in vivo studies.
Recombinant human IgG4-S228P bispecific isotype control antibodies good for in vitro and in vivo studies. Low or no specific binding to human, mouse, and rat samples tested.
Recombinant rat IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
In vivo Grade Recombinant Anti-mouse CD3e Mouse IgG2a Kappa Monoclonal Antibody (Clone: 500A2). Isotype: Mouse IgG2a kappa. Purity: >95%.
Recombinant rat IgG2b isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant human IgG4 kappa isotype control mutants, hIgG4 S228P and SPLEPG, good for in vivo and in vitro studies. Low or no specific binding to human samples tested. Humanized variable regions and hIgG4 kappa constant regions. The chimeric...
